user

KeifeRx

Biotechnology Research

View the employees at

KeifeRx

Overview

KeifeRx is an emerging clinical-stage biopharmaceutical company developing novel and optimized, low dose, orally delivered tyrosine kinase inhibitors (TKIs) for the treatment of multiple, high-need neurodegenerative and immune diseases.

  • Virginia

    Virginia, Elm Walk, Ward 2, Washington, District of Columbia, 20245, United States

    Get Direction